Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
01 1Medichem S.A.
02 1AX Pharmaceutical Corp
03 1Asclemed USA, Inc.
04 1Derivados Quimicos
05 2Dipharma Francis Srl
06 1FLOWCHEM PHARMA PRIVATE LIMITED
07 1Fagron Inc
08 1Galenova Inc
09 1Harman Finochem Limited
10 1Hetero Drugs Limited
11 1Jubilant Pharmova Limited
12 1Kalchem International inc
13 1LETCO MEDICAL, LLC
14 1MYLAN LABORATORIES LIMITED
15 1Medisca Inc.
16 1Professional Compounding Centers of America
17 1R.L.Fine Chem Private Limited
18 1Vasudha Pharma Chem Limited
19 1Village Pharma LLC
20 2Xenex Laboratories Inc
01 1CYCLOBENZAPRINE
02 1CYCLOBENZAPRINE HCL
03 7CYCLOBENZAPRINE HYDROCHLORIDE
04 1Cyclobenzaprine Hcl
05 1Cyclobenzaprine Hudrochloride
06 10Cyclobenzaprine Hydrochloride
07 1GABAPENTIN
01 4Canada
02 6India
03 2Italy
04 1Latvia
05 1Netherlands
06 2Spain
07 5U.S.A
08 1United Kingdom
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
NDC Package Code : 53296-0003
Start Marketing Date : 2010-03-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59349-0014
Start Marketing Date : 2018-11-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0050
Start Marketing Date : 2016-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0631
Start Marketing Date : 2004-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0483
Start Marketing Date : 2004-09-01
End Marketing Date : 2027-09-30
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 60592-041
Start Marketing Date : 2019-11-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 62991-1040
Start Marketing Date : 2011-09-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-0395
Start Marketing Date : 2012-03-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0118
Start Marketing Date : 2021-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 65015-722
Start Marketing Date : 2015-01-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Miosan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Miosan, including repackagers and relabelers. The FDA regulates Miosan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Miosan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Miosan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Miosan supplier is an individual or a company that provides Miosan active pharmaceutical ingredient (API) or Miosan finished formulations upon request. The Miosan suppliers may include Miosan API manufacturers, exporters, distributors and traders.
click here to find a list of Miosan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Miosan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Miosan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Miosan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Miosan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Miosan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Miosan suppliers with NDC on PharmaCompass.
We have 20 companies offering Miosan
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
